These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38895887)
21. Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises. Hagedorn JM; Monico EC Pediatr Emerg Care; 2019 Jan; 35(1):78-79. PubMed ID: 27902670 [TBL] [Abstract][Full Text] [Related]
22. Daily pain in adults with sickle cell disease-a different perspective. van Tuijn CF; Sins JW; Fijnvandraat K; Biemond BJ Am J Hematol; 2017 Feb; 92(2):179-186. PubMed ID: 27880985 [TBL] [Abstract][Full Text] [Related]
23. Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old. Gianni W; Madaio AR; Ceci M; Benincasa E; Conati G; Franchi F; Galetti G; Nieddu A; Salani B; Zuccaro SM J Pain Symptom Manage; 2011 Apr; 41(4):707-14. PubMed ID: 21145700 [TBL] [Abstract][Full Text] [Related]
24. Management of pain due to sickle cell disease. Johnson L; Carmona-Bayonas A; Tick L J Pain Palliat Care Pharmacother; 2008; 22(1):51-4. PubMed ID: 19042824 [TBL] [Abstract][Full Text] [Related]
25. Transdermal buprenorphine (Butrans) for chronic pain. Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936 [TBL] [Abstract][Full Text] [Related]
26. Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases. Schriek P Support Care Cancer; 2004 Dec; 12(12):882-4. PubMed ID: 15480815 [TBL] [Abstract][Full Text] [Related]
27. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland. Przeklasa-Muszynska A; Dobrogowski J Curr Med Res Opin; 2011 Jun; 27(6):1109-17. PubMed ID: 21456888 [TBL] [Abstract][Full Text] [Related]
28. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease. Knight LMJ; Onsomu EO; Bosworth HB; Crawford RD; DeMartino T; Glassberg J; Paice JA; Miller CN; Richardson L; Tanabe P Adv Emerg Nurs J; 2019; 41(1):86-97. PubMed ID: 30702538 [TBL] [Abstract][Full Text] [Related]
29. Morphine for the treatment of pain in sickle cell disease. Gupta M; Msambichaka L; Ballas SK; Gupta K ScientificWorldJournal; 2015; 2015():540154. PubMed ID: 25654130 [TBL] [Abstract][Full Text] [Related]
30. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease. Puri L; Nottage KA; Hankins JS; Anghelescu DL Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040 [TBL] [Abstract][Full Text] [Related]
31. Perioperative Buprenorphine Management: A Multidisciplinary Approach. Hickey T; Abelleira A; Acampora G; Becker WC; Falker CG; Nazario M; Weimer MB Med Clin North Am; 2022 Jan; 106(1):169-185. PubMed ID: 34823729 [TBL] [Abstract][Full Text] [Related]
32. Pain management in adults with sickle cell disease in a medical center emergency department. Solomon LR J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290 [TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain. James IG; O'Brien CM; McDonald CJ J Pain Symptom Manage; 2010 Aug; 40(2):266-78. PubMed ID: 20541900 [TBL] [Abstract][Full Text] [Related]